# Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

> **NCT05358704** · PHASE2 · SUSPENDED · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 38 (estimated)

## Conditions studied

- Cancer of Rectum

## Interventions

- **DRUG:** combination of drugs (chemoradiation (capecitabine and radiation) + FOLFOXIRI (Oxaliplatin, leucovorin, irinotecan, and fluorouracil)

## Key facts

- **NCT ID:** NCT05358704
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2022-05-13
- **Primary completion:** 2027-12-30
- **Final completion:** 2028-01-30
- **Target enrollment:** 38 (ESTIMATED)
- **Why stopped:** no slots available
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05358704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05358704, "Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05358704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*